These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23642435)
1. Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery. Vashakidze S; Gogishvili S; Nikolaishvili K; Dzidzikashvili N; Tukvadze N; Blumberg HM; Kempker RR Ann Thorac Surg; 2013 Jun; 95(6):1892-8. PubMed ID: 23642435 [TBL] [Abstract][Full Text] [Related]
2. Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Kang MW; Kim HK; Choi YS; Kim K; Shim YM; Koh WJ; Kim J Ann Thorac Surg; 2010 May; 89(5):1597-602. PubMed ID: 20417785 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
4. Adjunctive surgery improves treatment outcomes among patients with multidrug-resistant and extensively drug-resistant tuberculosis. Gegia M; Kalandadze I; Kempker RR; Magee MJ; Blumberg HM Int J Infect Dis; 2012 May; 16(5):e391-6. PubMed ID: 22425494 [TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series. Wang L; Xia F; Li F; Qian X; Zhu Y; Chen H; Bian A; Wang J; Zhang M; Li H; Han J; Jiang N; Xu N; Song Y Medicine (Baltimore); 2017 Dec; 96(50):e9109. PubMed ID: 29390307 [TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection in the treatment of 43 patients with well-localized, cavitary pulmonary multidrug-resistant tuberculosis in Shanghai. Xie B; Yang Y; He W; Xie D; Jiang G Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):455-9. PubMed ID: 23748869 [TBL] [Abstract][Full Text] [Related]
11. Surgery offers high cure rates in multidrug-resistant tuberculosis. Yaldiz S; Gursoy S; Ucvet A; Kaya SO Ann Thorac Cardiovasc Surg; 2011; 17(2):143-7. PubMed ID: 21597410 [TBL] [Abstract][Full Text] [Related]
12. [Adjuvant surgical resection for multidrug-resistant tuberculosis: A review]. Mordant P; Henry B; Morel S; Robert J; Veziris N; Le Dû D; Frechet-Jachym M; Similowski T; Caumes É; Riquet M; Le Pimpec-Barthes F Rev Mal Respir; 2014 Jun; 31(6):511-24. PubMed ID: 25012037 [TBL] [Abstract][Full Text] [Related]
13. Risk factor analysis of postoperative complications after adjunctive pulmonary resection in patients with multidrug-resistant tuberculosis: A multi-institutional study. Huang WL; Chien ST; Yu MC; Chang BS; Yen YT; Wu MH; Tseng YL J Microbiol Immunol Infect; 2023 Oct; 56(5):1064-1072. PubMed ID: 37586914 [TBL] [Abstract][Full Text] [Related]
14. Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference? Balabanova Y; Ignatyeva O; Fiebig L; Riekstina V; Danilovits M; Jaama K; Davidaviciene E; Radiulyte B; Popa CM; Nikolayevskyy V; Drobniewski F Thorax; 2016 Sep; 71(9):854-61. PubMed ID: 27012887 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066 [TBL] [Abstract][Full Text] [Related]
16. Adjunctive surgery versus medical treatment among patients with cavitary multidrug-resistant tuberculosis. Vashakidze SA; Gogishvili SG; Nikolaishvili KG; Avaliani ZR; Chandrakumaran A; Gogishvili GS; Magee M; Blumberg HM; Kempker RR Eur J Cardiothorac Surg; 2021 Dec; 60(6):1279-1285. PubMed ID: 34297819 [TBL] [Abstract][Full Text] [Related]
17. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center. Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663 [TBL] [Abstract][Full Text] [Related]
18. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Skrahin A; Ahmed RK; Ferrara G; Rane L; Poiret T; Isaikina Y; Skrahina A; Zumla A; Maeurer MJ Lancet Respir Med; 2014 Feb; 2(2):108-22. PubMed ID: 24503266 [TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131 [TBL] [Abstract][Full Text] [Related]
20. Extensively drug-resistant tuberculosis in the United States, 1993-2007. Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]